Union Square Ventures recently closed a $900 million fund, marking a strategic pivot to address larger market outcomes and the rapid evolution of AI. The firm maintains a thesis-driven approach, prioritizing early-stage investments and "obliterate, don't automate" strategies, where AI democratizes high-level expertise to restructure entire markets. By focusing on the "Rebel Alliance"—developers leveraging open-source and open-weight models—the firm avoids dependency on closed-stack incumbents. Investment decisions rely on a combination of product-native intuition, cohort retention data, and the ability of founders to navigate non-linear growth paths. Despite the increased capital, the firm remains committed to small-fund dynamics, seeking generational companies that can expand their total addressable market through synergistic product lines, such as Abridge’s evolution in healthcare, rather than relying on vanity metrics like annual recurring revenue.
Sign in to continue reading, translating and more.
Open full episode in Podwise